AMED

Amedisys

Delisted

AMED was delisted on the 14th of August, 2025.

283 hedge funds and large institutions have $3.9B invested in Amedisys in 2019 Q3 according to their latest regulatory filings, with 31 funds opening new positions, 106 increasing their positions, 104 reducing their positions, and 32 closing their positions.

New
Increased
Maintained
Reduced
Closed

more capital invested

Capital invested by funds: $ → $

more ownership

Funds ownership:

more repeat investments, than reductions

Existing positions increased: | Existing positions reduced:

less funds holding

Funds holding:

3% less first-time investments, than exits

New positions opened: 31 | Existing positions closed: 32

44% less call options, than puts

Call options by funds: $23.8M | Put options by funds: $42.2M

Holders
283
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
$23.8M
Puts
$42.2M
Net Calls
Net Calls Change

Top Buyers

1 +$84.6M
2 +$71.2M
3 +$27.7M
4
T. Rowe Price Associates
T. Rowe Price Associates
Maryland
+$18.6M
5
BlackRock
BlackRock
New York
+$16.9M
Name Holding Trade Value Shares
Change
Change in
Stake
226
$251K
227
$246K
228
$244K
229
$229K
230
$225K
231
$210K
232
$210K
233
$171K
234
$168K
235
$133K
236
$131K
237
$115K
238
$108K
239
$106K
240
$105K
241
$99K
242
$85K
243
$80K
244
$77K
245
$70K
246
$61K
247
$58K
248
$55K
249
$51K
250
$48K